Table 1 Basic clinical characteristics and subgroup frequencies of CYB5Aalt positive and negative patients in cohort 1
From: An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse
| Â | CYB5Aalt-status | |
|---|---|---|
positive (n = 9) | negative (n = 41) | |
median BM blast count (%) at ID | 88 | 92 |
median age at ID (years) | 18 | 15 |
median time to REL (days) | 615 | 744 |
samples | ||
 adult (n = 24) | 5 | 19 |
 pediatric (n = 26) | 4 | 22 |
sex | ||
 male (n = 27) | 4 | 23 |
 female (n = 23) | 5 | 18 |
molecular subgroup | ||
 NH (n = 4) | 2 | 2 |
 HeH (n = 6) | 3 | 3 |
 LH (n = 4) | 1 | 3 |
 Ph-like (n = 12) | 1 | 11 |
 DUX4r (n = 12) | 0 | 12 |
 Unknown (n = 3) | 0 | 3 |
 BCL2r (n = 2) | 0 | 2 |
 PAX5mut (n = 2) | 0 | 2 |
 PAX5r (n = 1) | 0 | 1 |
 MEF2Dr (n = 1) | 0 | 1 |
 MLLr (n = 2) | 0 | 2 |
 ZNF384f (n = 2) | 0 | 2 |